We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Health (UHS) Q1 Earnings: What's in the Cards?
Read MoreHide Full Article
Universal Health Services, Inc. (UHS - Free Report) is set to report first-quarter 2017 results on Apr 25, after the market closes. Last quarter, the company posted a positive earnings surprise of 0.56%. Let’s see how things are shaping up for this announcement.
Factors to be Considered this Quarter
Revenue per adjusted patient day for the Behavioral Health division is expected to have grown, continuing the trend displayed previously.
The company’s Acute Care division is also likely to deliver solid performance on the back of increasing adjusted admissions.
Capital expenditure of $520 million during 2016 is likely to show positive results, boosting the top line.
The company’s commitment to enhance shareholders’ value through share repurchases is likely to have positively impacted the bottom line by limiting share count.
Acquisition of Cambian Group at year-end 2016 is expected to have added to revenues.
However, increasing costs related to extinguishment of debt, reserves for settlements, legal judgments and lawsuits, and impairments of long-lived assets are likely to have limited bottom-line growth.
Universal Health Services, Inc. Price and EPS Surprise
Our proven model does not conclusively show that Universal Health is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.
Zacks ESP: Universal Health has an Earnings ESP of -0.49%. This is because the Most Accurate estimate is pegged at $2.05 and the Zacks Consensus Estimate stands at $2.06. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Universal Health carries a Zacks Rank #3. Though a favorable Zacks Rank increases the predictive power of ESP, we need a positive Earnings ESP to be confident about an earnings beat.
Conversely, we caution against Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some other companies from the medical sector that you may want to consider as these have the right combination of elements to post an earnings beat this quarter:
Anthem, Inc. has an Earnings ESP of +7.79% and a Zacks Rank #2. The company is set to report first-quarter earnings on Apr 26.
Humana, Inc. (HUM - Free Report) has an Earnings ESP of +2.06% and a Zacks Rank #2. The company is set to report first-quarter earnings on May 3.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Universal Health (UHS) Q1 Earnings: What's in the Cards?
Universal Health Services, Inc. (UHS - Free Report) is set to report first-quarter 2017 results on Apr 25, after the market closes. Last quarter, the company posted a positive earnings surprise of 0.56%. Let’s see how things are shaping up for this announcement.
Factors to be Considered this Quarter
Revenue per adjusted patient day for the Behavioral Health division is expected to have grown, continuing the trend displayed previously.
The company’s Acute Care division is also likely to deliver solid performance on the back of increasing adjusted admissions.
Capital expenditure of $520 million during 2016 is likely to show positive results, boosting the top line.
The company’s commitment to enhance shareholders’ value through share repurchases is likely to have positively impacted the bottom line by limiting share count.
Acquisition of Cambian Group at year-end 2016 is expected to have added to revenues.
However, increasing costs related to extinguishment of debt, reserves for settlements, legal judgments and lawsuits, and impairments of long-lived assets are likely to have limited bottom-line growth.
Universal Health Services, Inc. Price and EPS Surprise
Universal Health Services, Inc. Price and EPS Surprise | Universal Health Services, Inc. Quote
Earnings Whispers
Our proven model does not conclusively show that Universal Health is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.
Zacks ESP: Universal Health has an Earnings ESP of -0.49%. This is because the Most Accurate estimate is pegged at $2.05 and the Zacks Consensus Estimate stands at $2.06. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Universal Health carries a Zacks Rank #3. Though a favorable Zacks Rank increases the predictive power of ESP, we need a positive Earnings ESP to be confident about an earnings beat.
Conversely, we caution against Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some other companies from the medical sector that you may want to consider as these have the right combination of elements to post an earnings beat this quarter:
Amgen, Inc. (AMGN - Free Report) , which is set to report first-quarter earnings on Apr 26, has an Earnings ESP of +1.99% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Anthem, Inc. has an Earnings ESP of +7.79% and a Zacks Rank #2. The company is set to report first-quarter earnings on Apr 26.
Humana, Inc. (HUM - Free Report) has an Earnings ESP of +2.06% and a Zacks Rank #2. The company is set to report first-quarter earnings on May 3.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>